A Multicentric, Open Label, Randomized, Comparative, Parallel-group, Active-Controlled Phase III Clinical Trial to Evaluate Efficacy and Safety of oral tablets of Fixed-dose Combination of Cefixime 200 mg and Ofloxacin 200 mg in Comparison with Ofloxacin 200 mg Alone in Patients with Typhoid Fever

Trial Profile

A Multicentric, Open Label, Randomized, Comparative, Parallel-group, Active-Controlled Phase III Clinical Trial to Evaluate Efficacy and Safety of oral tablets of Fixed-dose Combination of Cefixime 200 mg and Ofloxacin 200 mg in Comparison with Ofloxacin 200 mg Alone in Patients with Typhoid Fever

Completed
Phase of Trial: Phase III

Latest Information Update: 26 Jun 2013

At a glance

  • Drugs Cefixime/ofloxacin; Ofloxacin
  • Indications Salmonella infections; Typhoid
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 29 Aug 2010 Status changed from recruiting to completed as reported by Clinical Trials Registry - India record.
    • 29 Aug 2010 Actual initiation date changed from 1 May 2010 to 8 Feb 2010 as reported by Clinical Trials Registry - India record.
    • 20 Jul 2010 Actual initiation date changed from 8 Feb 2010 to 1 May 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top